Cryo Cell International (CCEL) Accumulated Expenses (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of Accumulated Expenses data on file, last reported at $2.9 million in Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $2.9 million, down 33.42% year-over-year; the trailing twelve-month figure through Feb 2026 was $2.9 million (down 33.42% YoY), and the FY2025 annual result was $4.3 million, up 101.69% from the prior year.
• Accumulated Expenses eased to $2.9 million in Q1 2026 per CCEL's latest filing, from $4.3 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $4.3 million in Q1 2025 and troughed at $1.5 million in Q4 2022.
• A 5-year average of $2.7 million and a median of $2.3 million in 2025 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2022 and 2025: Accumulated Expenses slumped 50.43% in 2022, then soared 101.69% in 2025.
• A 5-year view of Accumulated Expenses shows it stood at $1.5 million in 2022, then jumped by 36.02% to $2.1 million in 2023, then climbed by 2.88% to $2.1 million in 2024, then surged by 101.69% to $4.3 million in 2025, then plunged by 32.51% to $2.9 million in 2026.
• Business Quant data shows CCEL's Accumulated Expenses at $2.9 million in Q1 2026, $4.3 million in Q4 2025, and $2.3 million in Q3 2025.